A leaked draft of a trade agreement under negotiation among 12 Pacific rim countries, including the US and Japan, contains language that could delay the entrance of generic competition for much-needed medicines and keep pharmaceutical prices high, according to the Foundation for Aids Research (amfAR), an international non-profit headquartered in New York. The organisation is lending its voice to those expressing similar concerns, like humanitarian organisation Doctors Without Borders. Although details of the proposed Trans-Pacific Partnership (TPP) have been kept confidential, leaked texts of the treaty have offered some clues, such as its embrace of intellectual property protections that go...